Publications

Export 2237 results:
Author [ Title(Desc)] Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
T
MJ Fleury.  2014.  Typologie des personnes atteintes de troubles mentaux graves avec ou non une addiction aux substances psychoactives.. Le Carrefour. March-April
MJ Fleury.  2014.  Typologie des personnes atteintes de troubles mentaux graves avec ou non une addiction aux substances psychoactives. Revue L’intervenant. 29
Huỳnh C, Tremblay J, MJ Fleury.  2016.  Typologies of Individuals Attending an Addiction Rehabilitation Center Based on Diagnosis of Mental Disorders.. J Subst Abuse Treat. 71:68-78.
MJ Fleury, Grenier G., Bamvita JM, Perreault M.  2011.  Typology of adults diagnosed with mental disorders based on socio-demographics and clinical and service use characteristics.. BMC Psychiatry. 11:67.
MJ Fleury, Grenier G, Cao Z, Meng X.  2020.  Typology of Currently or Formerly Homeless Individuals Based on Their Use of Health and Social Services.. Community Ment Health J.
MJ Fleury, Grenier G., Bamvita JM, Perreault M, Caron J..  2015.  Typology of individuals with substance dependence based on a Montreal longitudinal catchment area study.. Adm Policy Ment Health. 42(4):405-19.
MJ Fleury, Grenier G, Bamvita J-M, Ferland F.  2020.  Typology of patients who use emergency departments for mental and substance use disorders.. BJPsych Open. 6(4):e59.
Loranger C, Bamvita JM, MJ Fleury.  2019.  Typology of patients with mental health disorders and perceived continuity of care. Journal of Mental HealthJournal of Mental Health. :1-10.
MJ Fleury, Grenier G., Bamvita JM, Tremblay J.  2013.  Typology of persons with severe mental disorders.. BMC Psychiatry. 13:137.
Fortin M, Cao Z, MJ Fleury.  2018.  A typology of satisfaction with mental health services based on Andersen's behavioral model.. Soc Psychiatry Psychiatr Epidemiol. 53(6):587-595.
Perreault M, Mitchell E, Touré EHadj, MJ Fleury, Caron J..  2014.  Typology of sleep medication users and associated mental health and substance use from a Montreal epidemiological study.. J Popul Ther Clin Pharmacol. 21(2):e233-45.
U
Bednarz K, Alshafie W, Aufmkolk S, Desserteaux T, Markam PSingh, Storch K-F, Stroh T.  2020.  Ultradian Secretion of Growth Hormone in Mice: Linking Physiology With Changes in Synapse Parameters Using Super-Resolution Microscopy.. Front Neural Circuits. 14:21.
Dennis A, Thomas AG, Rawlings NB, Near J, Nichols TE, Clare S, Johansen-Berg H, Stagg CJ.  2015.  An Ultra-High Field Magnetic Resonance Spectroscopy Study of Post Exercise Lactate, Glutamate and Glutamine Change in the Human Brain.. Front Physiol. 6:351.
Evans AC, Karama S, Vasung L, Iturria-Medina Y.  2017.  Understanding brain development: a major step.. Lancet Neurol. 16(3):178-179.
Malla A, Dama M, Iyer SN, Joober R, Schmitz N, Shah JL, Mansour BIssaoui, Lepage M, Norman R.  2021.  Understanding Components of Duration of Untreated Psychosis and Relevance for Early Intervention Services in the Canadian Context: Comprendre les Composantes de la Durée de la Psychose Non Traitée et la Pertinence de Services D'intervention Précoce Dan. Can J Psychiatry. :706743721992679.
Haro JMaria, Altamura C, Corral R, Elkis H, Evans J, Malla A, Krebs M-O, Zink M, Bernasconi C, Lalonde J et al..  2015.  Understanding the impact of persistent symptoms in schizophrenia: Cross-sectional findings from the Pattern study.. Schizophr Res. 169(1-3):234-40.
Bhagwat N, Barry A, Dickie EW, Brown ST, Devenyi GA, Hatano K, DuPre E, Dagher A, Chakravarty MM, Greenwood CMT et al..  2021.  Understanding the impact of preprocessing pipelines on neuroimaging cortical surface analyses.. Gigascience. 10(1)
Pennestri M-H, Laganière C, Bouvette-Turcot A-A, Pokhvisneva I, Steiner M, Meaney MJ, Gaudreau H.  2018.  Uninterrupted Infant Sleep, Development, and Maternal Mood.. Pediatrics. 142(6)
Brown TE, Flood E, Sarocco P, Atkins N, Khachatryan A.  2017.  Unmet Medication Coverage Needs among Adults with Attention Deficit/Hyperactivity Disorder (ADHD).. Psychopharmacol Bull. 47(4):18-28.
Daneault J-G, Shah JL.  2020.  Unpacking the phenomenon of declining transition rates to first episode psychosis: The dyad of science and service reform in action.. Schizophr Res.
Boksa P, Joober R.  2014.  Update on the review process and publishing at the Journal of Psychiatry & Neuroscience. J Psychiatry Neurosci. 39:147-148.
Leuzy A, Zimmer ERigon, Heurling K, Rosa-Neto P, Gauthier S.  2014.  Use of amyloid PET across the spectrum of Alzheimer's disease: clinical utility and associated ethical issues.. Amyloid. 21(3):143-8.
Chuang Y-F, Breitner JCS, Chiu Y-L, Khachaturian A, Hayden K, Corcoran C, Tschanz J, Norton M, Munger R, Welsh-Bohmer K et al..  2014.  Use of diuretics is associated with reduced risk of Alzheimer's disease: the Cache County Study.. Neurobiol Aging. 35(11):2429-35.
MJ Fleury, Grenier G, Farand L, Ferland F.  2019.  Use of Emergency Rooms for Mental Health Reasons in Quebec: Barriers and Facilitators.. Adm Policy Ment Health. 46(1):18-33.
Saumier D, Pitman RK.  2018.  On the Use of Memory Update Mechanisms to Treat Patients: Response to Waits and Hoge.. Am J Psychiatry. 175(11):1145-1146.

Pages